PT Jayamas Medica Industri Tbk (IDX: OMED)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
180.00
0.00 (0.00%)
Nov 20, 2024, 4:00 PM WIB

OMED Income Statement

Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
1,835,0151,736,9901,739,0542,226,5731,994,5401,228,049
Revenue Growth (YoY)
5.62%-0.12%-21.90%11.63%62.42%-
Cost of Revenue
1,235,2191,185,0561,176,0451,322,544957,599782,576
Gross Profit
599,795551,934563,010904,0301,036,940445,473
Selling, General & Admin
261,195250,002198,309168,243186,715149,961
Other Operating Expenses
1,9471,057-7,5422,951736.383,335
Operating Expenses
263,141251,059190,767171,194187,451153,295
Operating Income
336,654300,875372,243732,836849,489292,178
Interest Expense
-19,800-19,581-20,805-21,840-9,008-384.94
Interest & Investment Income
56,47543,52014,37116,90914,94510,157
Currency Exchange Gain (Loss)
-4,1741,6546,7041,4455,821185.87
Other Non Operating Income (Expenses)
-435.38-341.03-403.98-328.64-149.77-146.62
EBT Excluding Unusual Items
368,720326,127372,109729,020861,098301,989
Gain (Loss) on Sale of Assets
-383.3435.590.04179.92583.7297.57
Pretax Income
368,336326,162372,109729,200861,681302,287
Income Tax Expense
78,24465,18081,602158,821168,81274,262
Earnings From Continuing Operations
290,093260,982290,507570,379692,869228,024
Minority Interest in Earnings
-2,190-1,622-4,725-7,687-7,359-1,816
Net Income
287,902259,360285,782562,692685,510226,208
Net Income to Common
287,902259,360285,782562,692685,510226,208
Net Income Growth
1.91%-9.25%-49.21%-17.92%203.04%-
Shares Outstanding (Basic)
27,05927,05927,05927,05927,45551,111
Shares Outstanding (Diluted)
27,05927,05927,05927,05927,45551,111
Shares Change (YoY)
-10.11%---1.44%-46.28%-
EPS (Basic)
10.649.5910.5620.8024.974.43
EPS (Diluted)
10.649.5910.5620.8024.974.43
EPS Growth
13.38%-9.25%-49.21%-16.72%464.16%-
Free Cash Flow
286,805-22,03117,549422,386228,771160,224
Free Cash Flow Per Share
10.60-0.810.6515.618.333.13
Dividend Per Share
2.8806.050-10.87017.000-
Dividend Growth
-9.15%---36.06%--
Gross Margin
32.69%31.78%32.37%40.60%51.99%36.27%
Operating Margin
18.35%17.32%21.40%32.91%42.59%23.79%
Profit Margin
15.69%14.93%16.43%25.27%34.37%18.42%
Free Cash Flow Margin
15.63%-1.27%1.01%18.97%11.47%13.05%
EBITDA
378,533335,378392,559752,142864,958305,786
EBITDA Margin
20.63%19.31%22.57%33.78%43.37%24.90%
D&A For EBITDA
41,87934,50420,31719,30715,46913,608
EBIT
336,654300,875372,243732,836849,489292,178
EBIT Margin
18.35%17.32%21.40%32.91%42.59%23.79%
Effective Tax Rate
21.24%19.98%21.93%21.78%19.59%24.57%
Source: S&P Capital IQ. Standard template. Financial Sources.